Research Site

Wellesley, Massachusetts 02481

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
A Study to Evaluate Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) Switching From Treatment With 4-Week Natalizumab Standard Interval Dosing (SID) in Relation to Continued SID Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
mi
from
Wellesley, MA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Research Site
mi
from
Wellesley, MA
Click here to add this to my saved trials